Radioimmunoassay (RIA) is an in vitro assay technique introduced in 1960 that uses antibodies to very sensitively measure antigen concentrations. It involves the separation of a protein from a mixture using the specificity of antibody-antigen binding, followed by quantitation using radioactivity. RIA utilizes competitive binding reactions and the measurement of radio emissions. Immunofluorescence also uses fluorescent-labeled antibodies but to detect specific target antigens. It emits greenish fluorescence under UV light that can be viewed under a fluorescence microscope. Both techniques have various medical applications like cancer detection, drug screening, and research.